DMTK - DermTech Inc
Close
0.094
-0.012 -12.766%
Share volume: 3,662,379
Last Updated: Wed 26 Jun 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.11
-0.01
-11.32%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-03 | 2022-08-08 | 2022-11-03 | 2023-03-02 | 2023-05-04 | 2023-08-03 | 2023-11-02 | |
| Assets | ||||||||
| Total Assets | 239.522 M | 216.112 M | 194.063 M | 202.075 M | 177.121 M | 157.074 M | 137.896 M | |
| Current Assets | 208.124 M | 183.865 M | 160.832 M | 136.037 M | 112.390 M | 93.742 M | 75.929 M | |
| Inventories | 763.000 K | 1.432 M | 1.391 M | 1.757 M | 1.574 M | 1.352 M | 1.196 M | |
| Other Current Assets | 3.260 M | 2.681 M | 4.212 M | 3.940 M | 2.348 M | 2.329 M | 2.928 M | |
| Short Term Investments | 3.260 M | 2.681 M | 4.212 M | 3.940 M | 2.348 M | 2.329 M | 2.928 M | |
| Total Receivables | 4.995 M | 5.962 M | 6.101 M | 4.172 M | 3.690 M | 3.865 M | 3.605 M | |
| Current Cash | 199.106 M | 173.790 M | 149.128 M | 126.168 M | 104.778 M | 86.196 M | 68.200 M | |
| Total Non-current Assets | 31.398 M | 32.247 M | 33.231 M | 66.038 M | 64.731 M | 63.332 M | 61.967 M | |
| Property Plant Equipment | 5.141 M | 4.916 M | 4.943 M | 6.375 M | 6.262 M | 6.074 M | 5.611 M | |
| Other Assets | 23.232 M | 23.861 M | 24.811 M | 56.175 M | 54.968 M | 53.791 M | 52.889 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 239.522 M | 216.112 M | 194.063 M | 202.075 M | 177.121 M | 157.074 M | 137.896 M | |
| Total liabilities | 36.041 M | 37.535 M | 39.075 M | 69.722 M | 69.879 M | 68.997 M | 64.832 M | |
| Total current liabilities | 14.424 M | 15.088 M | 16.986 M | 15.636 M | 16.138 M | 16.014 M | 12.636 M | |
| Accounts Payable | 1.575 M | 861.000 K | 2.997 M | 2.419 M | 1.680 M | 2.324 M | 1.703 M | |
| Other liabilities | 129.000 K | 24.000 K | 20.000 K | 5.000 K | 12.000 K | 6.000 K | 1.000 K | |
| Current long term debt | 1.815 M | 1.827 M | 1.712 M | 1.750 M | 1.853 M | 2.313 M | 2.978 M | |
| Long term debt | 21.488 M | 22.423 M | 22.069 M | 54.081 M | 53.729 M | 52.977 M | 52.195 M | |
| Other liabilities | 129.000 K | 24.000 K | 20.000 K | 5.000 K | 12.000 K | 6.000 K | 1.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 203.481 M | 178.577 M | 154.988 M | 132.353 M | 107.242 M | 88.077 M | 73.064 M | |
| Common stock | 29.836 M | 29.965 M | 30.096 M | 30.259 M | 30.557 M | 31.792 M | 33.835 M | |
| Retained earnings | -236.472 M | -266.052 M | -294.824 M | -323.047 M | -354.317 M | -385.680 M | -404.844 M |